177 related articles for article (PubMed ID: 38065243)
1. A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry.
Schenck L; Risteen B; Johnson LM; Koynov A; Bonaga L; Orr R; Hancock B
J Pharm Sci; 2024 Feb; 113(2):306-313. PubMed ID: 38065243
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
3. A Co-Processed API Approach for a Shear Sensitive Compound Affording Improved Chemical Stability and Streamlined Drug Product Processing.
Schenck L; Neri C; Jia X; Schafer W; Axnanda S; Canfield N; Li F; Shah V
J Pharm Sci; 2021 Sep; 110(9):3238-3245. PubMed ID: 34089710
[TBL] [Abstract][Full Text] [Related]
4. Continuous Feeding and Blending Demonstration with Co-Processed Drug Substance.
Erdemir D; Gawel J; Yohannes B; Yates P; Tang D; Ha K; Breza B; DiMaso E; Abebe A; Zombek J
J Pharm Sci; 2023 Aug; 112(8):2046-2056. PubMed ID: 36462708
[TBL] [Abstract][Full Text] [Related]
5. Combining Isolation-Free and Co-Processing Manufacturing Approaches to Access Room Temperature Ionic Liquid Forms of APIs.
Stocker MW; Tsolaki E; Harding MJ; Healy AM; Ferguson S
J Pharm Sci; 2023 Aug; 112(8):2079-2086. PubMed ID: 36806585
[TBL] [Abstract][Full Text] [Related]
6. Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material properties.
Schenck L; Koynov A; Cote A
Drug Dev Ind Pharm; 2019 Apr; 45(4):521-531. PubMed ID: 30609381
[TBL] [Abstract][Full Text] [Related]
7. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
8. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
[TBL] [Abstract][Full Text] [Related]
9. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
[TBL] [Abstract][Full Text] [Related]
10. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
Ticehurst MD; Marziano I
J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
[TBL] [Abstract][Full Text] [Related]
11. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.
Shikha S; Lee YW; Doyle PS; Khan SA
Mol Pharm; 2022 Nov; 19(11):4345-4356. PubMed ID: 36268657
[TBL] [Abstract][Full Text] [Related]
13. Current Trends in API Co-Processing: Spherical Crystallization and Co-Precipitation Techniques.
Dhondale MR; Nambiar AG; Singh M; Mali AR; Agrawal AK; Shastri NR; Kumar P; Kumar D
J Pharm Sci; 2023 Aug; 112(8):2010-2028. PubMed ID: 36780986
[TBL] [Abstract][Full Text] [Related]
14. Impact Of Excipient Variability On Drug Product Processing And Performance.
Peng Soh JL; Liew CV; Sia Heng PW
Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
[TBL] [Abstract][Full Text] [Related]
15. Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacture.
Leane M; Pitt K; Reynolds G; Tantuccio A; Moreton C; Crean A; Kleinebudde P; Carlin B; Gamble J; Gamlen M; Stone E; Kuentz M; Gururajan B; Khimyak YZ; Van Snick B; Andersen S; Misic Z; Peter S; Sheehan S
Pharm Dev Technol; 2024 Jun; 29(5):395-414. PubMed ID: 38618690
[TBL] [Abstract][Full Text] [Related]
16. Deep learning for continuous manufacturing of pharmaceutical solid dosage form.
Roggo Y; Jelsch M; Heger P; Ensslin S; Krumme M
Eur J Pharm Biopharm; 2020 Aug; 153():95-105. PubMed ID: 32535045
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
18. Direct compression high functionality excipient using coprocessing technique: a brief review.
Mirani AG; Patankar SP; Borole VS; Pawar AS; Kadam VJ
Curr Drug Deliv; 2011 Jul; 8(4):426-35. PubMed ID: 21235470
[TBL] [Abstract][Full Text] [Related]
19. Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Schubert MA; Vervaet C; De Beer T
Eur J Pharm Biopharm; 2019 Feb; 135():49-60. PubMed ID: 30582959
[TBL] [Abstract][Full Text] [Related]
20. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
